KWA
TGTX icon

Kingswood Wealth Advisors’s TG Therapeutics TGTX Stock Holding History

Kingswood Wealth Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351K Buy
6,384
+37
+0.6% +$1.51K 0.01% 721
2026
Q1 		$211K Buy
+6,347
New +$189K 0.01% 868
2025
Q4 		– Sell
-6,384
Closed -$231K – 912
2025
Q3 		$231K Sell
6,384
-1,900
-23% -$62.6K 0.01% 718
2025
Q2 		$298K Buy
8,284
+500
+6% +$18.6K 0.02% 573
2025
Q1 		$307K Buy
7,784
+200
+3% +$6.73K 0.03% 540
2024
Q4 		$228K Buy
+7,584
New +$218K 0.02% 700

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Kingswood Wealth Advisors's TGTX Position: Q2 2026 in Review

Kingswood Wealth Advisors increased its TG Therapeutics (TGTX) stake by 0.58% in Q2 2026, buying an estimated $1.51K and bringing the position to 6,384 shares worth $351K. The position accounts for 0.01% of the portfolio, ranked #721.

Kingswood Wealth Advisors first reported a position in TGTX in Q4 2024 and has held it in 6 quarters since. 428 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Kingswood Wealth Advisors held 6,384 shares of TG Therapeutics worth $351K as of Q2 2026.
  • Kingswood Wealth Advisors bought 37 TG Therapeutics shares in Q2 2026, an estimated $1.51K.
  • TG Therapeutics made up 0.01% of Kingswood Wealth Advisors's portfolio in Q2 2026, its #721 holding.
  • Kingswood Wealth Advisors first reported a position in TG Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 428 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Kingswood Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.